Guangzhou-Jinan Pharmaceutical Co., 100 million to increase capital and share of subsidiaries

Guang-ji Pharmaceutical (000952) February 22 Evening announcement, the company holding subsidiary of the Canton-Jinan Pharmaceutical (Mengzhou) Co., Ltd. Asset-liability ratio of 74.06%, in order to give full play to the Mengzhou company has the resources advantage, is conducive to Mengzhou company's future development, the company intends to increase capital to Mengzhou company. The company said that Mengzhou Company's another shareholder Mengzhou Golden Corn Limited Liability company decided not to participate in the increase in capital, and agreed to the company to subscribe to the 100 million Yuan Mengzhou company's proposed increase in the registered capital of 100 million yuan. After the completion of the replenishment, the Mengzhou company's registered capital (Paid-in capital) will be changed from 100 million yuan to 200 million yuan, the company's total contribution to Mengzhou company changed to 180 million yuan, the proportion of capital contribution from 80% to 90%.